Atlas Venture Fund Xi, L.P. Xilio Therapeutics, Inc. (XLO) insider trading activity

Atlas Venture Fund Xi, L.P. is > 10% Shareholder of Xilio Therapeutics, Inc.. Currently has a direct ownership of 2.02 Million shares of XLO, which is worth approximately $1.9 Million. The most recent transaction as insider was on Feb 08, 2024, when has been sold 733 shares (Common Stock) at a price of $0.64 per share, resulting in proceeds of $469. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.02M

0% 3M change

n/a 12M change

Total Value Held $1.9 Million

Atlas Venture Fund XI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 08 2024	SELL Open market or private sale	$469 $0.64 p/Share	733 Reduced 0.04%	2,019,563 Common Stock
Jan 12 2024	SELL Open market or private sale	$1,278 $0.83 p/Share	1,540 Reduced 0.08%	2,020,296 Common Stock
Jan 11 2024	SELL Open market or private sale	$1,362 $0.87 p/Share	1,566 Reduced 0.08%	2,021,836 Common Stock

Also insider at

DAWN

Day One Biopharmaceuticals, Inc. Healthcare

> 10% Shareholder

DYN

Dyne Therapeutics, Inc. Healthcare

IKNA

Ikena Oncology, Inc. Healthcare

> 10% Shareholder

THRD

Third Harmonic Bio, Inc. Healthcare

AVF